Vatelizumab
Product Specifications
CAS Number
1238217-55-4
Target
Integrin
Related Pathways
Cytoskeletal Signaling
Purity
0.9954
Bioactivity
Vatelizumab is a humanised monoclonal antibody targeting Integrin ?2?1 (very late antigen 2, VLA-2, CD49b), which enhances the frequency of regulatory T cells via the p38 MAPK signalling pathway and can be used for research into multiple sclerosis.
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
E0015-04F-Biotin 200 µL
UBE3A, CT (Ubiquitin-protein Ligase E3A, E6AP Ubiquitin-protein Ligase, Oncogenic Protein-associated Protein E6-AP, Human Papillomavirus E6-associated Protein, Renal Carcinoma Antigen NY-REN-54, E6AP, EPVE6AP, HPVE6A) (Biotin)
Ask
View Details